Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Irvine

Showing results (91-100 of 818) with videos related to

Pageof 82
Sort By:
Clinical and Experimental Immunology|September 1, 1977
Prevention of autoimmune thyroiditis in T cell-depleted rats by injections of crude thyroid extractD B Whitmore, W J Irvine
Proceedings of the Royal Society of Medicine|February 1, 1973
Clinical syndromes associated with thymic disordersE W Barnes, W J Irvine
Proceedings of the Royal Society of Medicine|August 1, 1974
Hormonal effects of synthetic ACTH analoguesA D Toft, W J Irvine
Nature Biotechnology|November 7, 2015
Big thinking for adjuvantsEric L Dane, Darrell J Irvine
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|July 11, 1998
Ketotifen treatment of active colitis in patients with 5-aminosalicylate intoleranceJ K Marshall, E J Irvine
Gut|June 1, 1997
Rectal corticosteroids versus alternative treatments in ulcerative colitis: a meta-analysisJ K Marshall, E J Irvine
Clinical Endocrinology|November 1, 1976
Ehe diagnosis and treatment of thyrotoxicosisW J Irvine, A D Toft
Methods in Molecular Biology (Clifton, N.J.)|October 9, 2016
Synthesis of Lymph Node-Targeting AdjuvantsMelissa C Hanson, Darrell J Irvine
Biochemical Pharmacology|July 15, 1988
Treatment of intact hepatocytes with the calcium ionophore A23187 perturbs both the synthesis and the degradation of the second messenger cyclic AMP. Actions on adenylate cyclase and cyclic AMP phosphodiesterase activitiesF J Irvine, M D Houslay
Gastroenterology|December 12, 1997
Therapeutic placebo in ulcerative colitis: fact or fiction?J K Marshall, E J Irvine
Pageof 82

Showing results (91-100 of 818) with videos related to

Sort By:
Pageof 82
Clinical and Experimental Immunology|September 1, 1977
Prevention of autoimmune thyroiditis in T cell-depleted rats by injections of crude thyroid extractD B Whitmore, W J Irvine
Proceedings of the Royal Society of Medicine|February 1, 1973
Clinical syndromes associated with thymic disordersE W Barnes, W J Irvine
Proceedings of the Royal Society of Medicine|August 1, 1974
Hormonal effects of synthetic ACTH analoguesA D Toft, W J Irvine
Nature Biotechnology|November 7, 2015
Big thinking for adjuvantsEric L Dane, Darrell J Irvine
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|July 11, 1998
Ketotifen treatment of active colitis in patients with 5-aminosalicylate intoleranceJ K Marshall, E J Irvine
Gut|June 1, 1997
Rectal corticosteroids versus alternative treatments in ulcerative colitis: a meta-analysisJ K Marshall, E J Irvine
Clinical Endocrinology|November 1, 1976
Ehe diagnosis and treatment of thyrotoxicosisW J Irvine, A D Toft
Methods in Molecular Biology (Clifton, N.J.)|October 9, 2016
Synthesis of Lymph Node-Targeting AdjuvantsMelissa C Hanson, Darrell J Irvine
Biochemical Pharmacology|July 15, 1988
Treatment of intact hepatocytes with the calcium ionophore A23187 perturbs both the synthesis and the degradation of the second messenger cyclic AMP. Actions on adenylate cyclase and cyclic AMP phosphodiesterase activitiesF J Irvine, M D Houslay
Gastroenterology|December 12, 1997
Therapeutic placebo in ulcerative colitis: fact or fiction?J K Marshall, E J Irvine
Pageof 82